RespireRx Pharmaceuticals (RSPI) SEC Filings & 10K Form

$0.0009
0.00 (0.00%)
(As of 04/25/2024 ET)

Recent RespireRx Pharmaceuticals SEC Filings

DateFilerForm TypeView
02/02/2024
7:30 AM
RespireRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2024
7:45 AM
RespireRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2023
7:45 AM
RespireRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2023
3:05 PM
RespireRx Pharmaceuticals (Filer)
Form NT 10-Q
10/12/2023
8:00 AM
RespireRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2023
7:45 AM
RespireRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2023
7:52 AM
RespireRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2023
3:10 PM
RespireRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2023
7:45 AM
RespireRx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2023
3:16 PM
RespireRx Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (OTCMKTS:RSPI) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners